Moreover, PGRN regulates miR-138, which targets histone deacetylase 4 and affects NF-κB levels in RA [365], attenuates the inhibitory effects of TNFα on osteoblast differentiation, and prevents cartilage oligomeric matrix protein (COMP) degradation [365]. Here, COMP is linked to rheumatoid arthritis.